Get key Market Research Reports and Insightful Company Profiles
The pharmerging markets are highly fragmented due to the presence of numerous small and large vendors. Most of the international pharmaceutical companies are facing challenges such as price pressure, regulatory constraints, and competition from local and other international pharmaceutical companies in the pharmerging markets.
Market outlook of the pharmerging markets
Technavios research analyst predicts the pharmerging markets to grow steadily at a CAGR of 13% during the forecast period. The increase in public and private healthcare insurance is the primary growth driver for this market. The governments of various pharmerging countries such as India have implemented several schemes that can be availed by patients to obtain free treatment for different diseases. Also, public and private multinational firms in collaboration with various insurance companies are providing healthcare coverage to their employees as a part of the employee welfare scheme, which is further leveraging people to seek treatment for the existing diseases.
The increase in healthcare spending by governments of pharmerging countries are expected to boost the market growth during the forecast period. Governments and pharmaceutical companies in these regions are making huge investments to improve accessibility to healthcare services, which is primarily driven by rising incomes, macroeconomic expansion, and government-supported policies and programs.
Browse Detail Report With TOC @ http://www.hexareports.com/report/pharmerging-market/details
Segmentation and analysis of the pharmerging markets
Tier I countries (China)
Tier II countries (Brazil, India, and Russia)
Tier III countries (Poland, Argentina, Turkey, Mexico, Venezuela, Romania, Saudi Arabia, Colombia, Vietnam, South Africa, Algeria, Thailand, Indonesia, Egypt, Pakistan, Nigeria, and Ukraine)
The Tier I region (China) dominated the market during 2015, with a market share of 45%. An ageing population, increase in healthcare spending, and rise in market opportunities in suburban and rural areas are the main factors fueling the growth of the market in China.
Competitive landscape and key vendors
The pharmerging markets are highly fragmented due to the presence of numerous small and large vendors. Most of the international pharmaceutical companies are facing challenges such as price pressure, regulatory constraints, and competition from local and other international pharmaceutical companies in the pharmerging markets. The competitive environment in the market is expected to intensify with an increase in product extensions, technological innovations, and increase in mergers and acquisitions.
The leading vendors in the market are –
AstraZeneca
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Other prominent vendors in the market include Abbott Laboratories, AbbVie, Alexion Pharmaceuticals, Allergan, Amgen, Aspen, Astellas Pharma, Baxter, Bayer, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Chugai Pharmaceutical, CSL Behring, Daiichi Sankyo, Dainippon Sumitomo Pharma, Eisai, Eli Lilly, Endo Health Pharmaceuticals, F. Hoffmann-La Roche, Fresenius, Gilead, Grifols, H. Lundbeck, Hospira, Johnson & Johnson, Kyowa Hakko Kirin, Mallinckrodt Pharmaceuticals, Menarini, Mitsubishi Tanabe Pharma, Mylan, Novo Nordisk, Otsuka, Shire, STADA Arzneimittel, Sun Pharmaceutical, Takeda Pharma, Teva Pharmaceutical, UCB, and Valeant Pharmaceuticals.
Related Reports:
Alzheimer Disease Drugs Markets in China:
http://www.hexareports.com/report/alzheimer-disease-drugs-markets-in-china
Osteoporosis Drugs Markets in China:
http://www.hexareports.com/report/osteoporosis-drugs-markets-in-china
Key questions answered in the report include
What will the market size and the growth rate be in 2020
What are the key factors driving the pharmerging markets
What are the key market trends impacting the growth of the pharmerging markets
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the vendors in the pharmerging markets
Trending factors influencing the market shares of Tier I, Tier II, and Tier III countries
What are the key outcomes of the five forces analysis of the pharmerging markets
Technavio also offers customization on reports based on specific client requirement.
Related reports:
Global Pharmaceutical Packaging Market 2015-2019
Global Active Pharmaceutical Ingredients Market 2015-2019
Global Pharmaceuticals Wholesale and Distribution Market 2015-2019
Pharmaceutical Packaging Market in Europe 2015-2019
Pharmaceutical Packaging Market in North America 2015-2019
Pharmaceutical Logistics Market in the APAC 2015-2019
Active Pharmaceutical Ingredients (API) Market in India 2015-2019
Request A Sample copy of This Report @ http://www.hexareports.com/sample/61627
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Media Contact
Company Name: Hexa Reports
Contact Person: Ryan Shaw
Email: Send Email
Phone: 1-800-489-3075
Address:Felton Office Plaza, 6265 Highway 9
City: Felton
State: California
Country: United States
Website: http://www.hexareports.com/report/pharmerging-market/details